Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02844517 · ClinicalTrials.gov registry record · NA
International Diabetes Closed Loop (iDCL) Trial: Research Site Training Protocol
A NA study, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
NCT02844517 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 43 participants.
The verdict
NCT02844517, a NA study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
Study Summary
The objective of the study is for clinical staff to gain experience using the proposed artificial pancreas system named inControl and the inControl Cloud and assess 24/7 in-home usability prior to initiating a large randomized controlled trial.
Interventions
- DEVICE Artificial Pancreas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2016-11 |
| Est. Completion | 2017-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02844517
The ClinicalTrials.gov registry entry for NCT02844517 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Artificial Pancreas is the first listed.
NCT02844517 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02844517 about?
NCT02844517 is a clinical study titled "International Diabetes Closed Loop (iDCL) Trial: Research Site Training Protocol". The objective of the study is for clinical staff to gain experience using the proposed artificial pancreas system named inControl and the inControl Cloud and assess 24/7 in-home usability prior to initiating a large randomized controlled trial.
What is the current status of trial NCT02844517?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2016-11. Estimated completion is 2017-10.
What interventions are being tested in trial NCT02844517?
The interventions under investigation include: Artificial Pancreas (DEVICE).
Who is sponsoring clinical trial NCT02844517?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.